Oxytocin 100 IU / Apomorphine 4mg 10 -Troche

$80.00
Free shipping on all US orders
Got any questions? Contact us

Supplied by U.S. pharmacies.

Description

Formulation Facts

  • The preparation contains oxytocin and apomorphine prepared as an oral troche.
  • Apomorphine is classified by the Food and Drug Administration (FDA) substance registry as a dopamine agonist.[5]

The oxytocin apomorphine troche is a compounded oral medication that combines two distinct active ingredients into a dissolvable troche. The cited oxytocin studies evaluated nasal sprays rather than this combination troche.[2][3]

Ingredients and Form

Combining two active ingredients into an oral troche creates a distinct preparation that differs from separate single-agent products.

Primary Clinical Research and Evidence Boundaries

In a randomized crossover trial published in Fertility and Sterility, nasal oxytocin and placebo both produced similar improvements in female sexual function scores without a significant difference between groups.[2] A separate randomized laboratory study in healthy women likewise determined that nasal oxytocin did not produce a significant change in measured physiological sexual parameters compared to placebo.[3]

A comparative crossover trial in erectile dysfunction compared apomorphine with sildenafil, but did not assess a combination with oxytocin.[6] These isolated investigations do not substantiate claims of increased intimacy, emotional connection, or sexual arousal for this compounded troche formulation.[2][3][6]

Frequently asked questions

What active ingredients are in this compounded troche?

This oral troche contains oxytocin and apomorphine as its active ingredients.

Is this combination the same as taking oxytocin alone?

The combination differs from single-agent therapy because it adds apomorphine, a dopamine agonist.[5]

Do nasal oxytocin studies demonstrate that the troche is effective?

The cited nasal oxytocin trials do not demonstrate the efficacy of this oral combination troche.[2][3] The cited trials examined nasal sprays in female cohorts and found no significant improvement in sexual function outcomes compared to placebo.[2][3] Delivery through an oral dissolving troche represents a different route that cannot rely on nasal research findings.[2]

Does research substantiate claims of guaranteed arousal or bonding?

The cited studies do not establish improved arousal, desire or emotional connection for this compounded troche.[2][3][6]

Research and information sources

  1. Opt Health: How It Works
  2. Intranasal oxytocin clinical trial (PubMed 26151620)
  3. Intranasal oxytocin study (PubMed 29596150)
  4. FDA: Compounding and FDA Questions and Answers
  5. FDA substance registry: Apomorphine
  6. Sildenafil and apomorphine comparative study (PubMed 15180621)
  7. FDA: Archived Apomorphine Film Prescribing Information
  8. Opt Health: Get Started

Safety Context and Regulatory Status

An archived FDA label for a different apomorphine product describes blood-pressure and mouth-irritation concerns.[7] Those reports concern a different product and do not establish the risks or side-effect frequency of this compounded troche.[7]

Compounded medications are not FDA-approved.[4]

Consult an Opt Health Physician

Opt Health connects members with licensed physicians who evaluate comprehensive blood tests, medical background, and health goals.[1][8] A personalized care plan is established only after individual clinical assessment, with no guarantee of a specific prescription.[1][8]

Get started with Opt

This content is for informational purposes and does not replace evaluation, diagnosis, or treatment by a qualified medical professional.